Related Experiment Video
Updated: Feb 13, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Addressing the selectivity and toxicity of antiviral nucleosides
12158 Gilead Sciences Inc. , Foster City, USA.
Abstract:
Nucleoside and nucleotide analogs have played significant roles in antiviral therapies and are valued for their impressive potency and high barrier to resistance. They have been approved for treatment of herpes simplex virus-1, HIV, HBV, HCV, and influenza, and new drugs are being developed for the treatment of RSV, Ebola, coronavirus MERS, and other emerging viruses. However, this class of compounds has also experienced a high attrition rate in clinical trials due to toxicity. In this review, we discuss the utility of different biochemical and cell-based assays and provide recommendations for assessing toxicity liability before entering animal toxicity studies.
Related Concept Videos
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Frequency-dependent Selection
The Antiviral System of Bacteria and Archaea: CRISPR
What is Natural Selection?
Toxicity Testing in Animals
Antibiotic Selection

